Schedule 13D ownership disclosure

Dr Reddy's Laboratories Ltd

American depositary shares, each representing one equity share · CUSIP: 256135203

Event date: 2025-09-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • G.V. PrasadReported CIK 0001663911

    Shares: 108,813,010.00 · Class: 13.04%

  • K. Satish ReddyReported CIK 0001663790

    Shares: 113,356,510.00 · Class: 13.58%

  • GVP Family TrustReported CIK 0002064996

    Shares: 96,095,920.00 · Class: 11.51%

  • VSD Family TrustReported CIK 0002060584

    Shares: 75,630,620.00 · Class: 9.06%

  • G. AnuradhaReported CIK 0002067759

    Shares: 96,141,945.00 · Class: 11.52%

  • Deepti ReddyReported CIK 0002060570

    Shares: 75,656,320.00 · Class: 9.07%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001575872-25-000580
Form type
SCHEDULE 13D/A
Filer
DR REDDYS LABORATORIES LTD
CIK
CIK 1135951
Filed
Sep 18, 2025
Reporting period
Sep 17, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub